Approvals (Drugs@FDA)

SUGAMMADEX SODIUM

HIKMA · SUGAMMADEX SODIUM

ANDA218727Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA218727
Sponsor name
HIKMA
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260728
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    SUGAMMADEX SODIUM
    Reference standard
    No
    Dosage form
    SOLUTION
    Route
    INTRAVENOUS
    Marketing status
    Prescription
    Te code
    AP
    Active ingredients
    1. Name
      SUGAMMADEX SODIUM
      Strength
      EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Harmonized identifiers (openFDA)
Application number
ANDA218727
Brand name
SUGAMMADEX
Generic name
SUGAMMADEX
Manufacturer name
Hikma Pharmaceuticals USA Inc.
Product NDC
0641-6270
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
SUGAMMADEX SODIUM
RxCUI
2748156
SPL ID
b9354354-17fa-4c37-95b5-4677a64afe3d
SPL set ID
c8c1dccf-9be3-49b2-a5d9-46c2b9ca0193
Package NDC
0641-6270-01, 0641-6270-10
UNII
ERJ6X2MXV7
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.